pluripotential stem cells that give rise, via daughter cells of restricted self- Kingdom. renewal capacity and high differentiation probability (transit-amplifying cells), to interfollicular epidermis, hair follicles, and sebaceous glands. In vivo, Correspondence: Fiona M. Watt transit-amplifying cells are actively cycling, whereas stem cells divide E-mail: watt@icrf.icnet.uk infrequently. Experiments with cultured human keratinocytes suggest that c-Myc promotes epidermal-stem cell differentiation. However, Myc is a Proliferation was stimulated, but interfollicular keratinocytes still underwent normal terminal differentation. Hair follicles were abnormal, and sebaceous differentiation was stimulated at the expense of hair differentiation. The activation of c-Myc by a single application of 4-hydroxy-tamoxifen was as effective as continuous treatment in stimulating proliferation and sebocyte differentiation, and the c-Myc-induced phenotype continued to develop even after the grafting of treated skin to an untreated recipient.
Background
ture has defined a number of molecules that regulate exit from the stem cell compartment [1, 2, 5] . One is the The epidermis is maintained throughout adult life by pluripotential stem cells whose progeny differentiate to protooncogene c-Myc [5, 6] . The activation of c-Myc causes a progressive reduction in the growth rate of culform interfollicular epidermis, hair follicles, and sebaceous glands [1] [2] [3] [4] . Stem cell daughters that are destined to tured human keratinocytes without inducing apoptosis: this is due to a marked stimulation of terminal differentiaundergo terminal differentiation divide a small number of times in the basal layer before withdrawing from the tion. c-Myc acts selectively on stem cells in culture and drives them into the transit-amplifying compartment. cell cycle; these cells are known as transit-amplifying cells. One role of transit-amplifying cells is, as their name imThen, after a few rounds of division, they undergo terminal differentiation. plies, to increase the number of differentiated cells that are generated by each stem cell division; in normal, undamaged epidermis, stem cells divide infrequently,
In clonal cultures of human keratinocytes, only differentiwhereas transit-amplifying cells are actively cycling [1, 3] .
ation into interfollicular epidermis can be examined [1, A second feature of transit-amplifying cells, by analogy 6], and so it is not possible to evaluate the effects of c-Myc with the haemopoietic system [2] , may be that their differon lineage commitment in vitro. In addition, stem cells entiation potential is restricted to a particular lineage; are actively cycling in culture, and thus the ability of Myc however, at present little is known about lineage committo recruit quiescent stem cells into the cell cycle cannot ment in the epidermis.
not be evaluated [6] . Furthermore, Myc is a potent oncogene [7, 8] that has been reported to cause epidermal neoplasia [9] . Constitutive expression of c-Myc via the Clonal analysis of human-epidermal keratinocytes in cul- loricrin promoter, which targets both the basal and suthe basal layer of interfollicular epidermis and along the entire length of the outer-root sheath of the hair follicle prabasal (differentiating) epidermal layers, results in suprabasal proliferation and reduced expression of terminal [11] . It thus includes both stem and transit-amplifying cells [1, 4] . Immunostaining transgenic mouse skin condifferentiation markers in transgenic mice [10] . When an inducible Myc transgene is selectively expressed in the firmed that the transgene was correctly expressed in the basal layer of the epidermis and outer-root sheath of hair differentiating layers of mouse epidermis via the involucrin promoter, activation of c-Myc suppresses differentiafollicles ( Figure 1b and unpublished data). Human c-Myc was also detected by the Western blotting of extracts of tion and causes neoplastic changes; because cells expressing activated Myc are not permanent tissue residents, the keratinocytes cultured from transgenic but not from wildtype mice (Figure 1c ). phenotype is, however, fully reversible [9] .
While the effects of c-Myc on human keratinocytes in Although c-MycER protein was constitutively expressed in basal keratinocytes, as expected none of the founder culture are not consistent with the phenotype of transgenic mice expressing Myc in the epidermis, neither of lines showed any phenotype unless 4-hydroxy-tamoxifen (OHT) was applied to activate Myc function [6, 9, 12] . the transgene promoters evaluated so far [9, 10] has selectively targeted the basal layer, where the stem cells reside.
In addition, we saw no systemic effects of topical OHT application to the dorsal skin of K14MycER mice, even Therefore, to investigate the effects of c-Myc on the stem cell compartment in vivo, we have used the keratin 14 though the K14 promoter is active in some internal epithelia [13] . OHT had no effects on the skin, including the promoter [11] to express an inducible form of Myc, c-MycER TM , in the basal layer of transgenic mouse epiderhair cycle, of wild-type mice. As a further control, two founder lines expressing a mutant c-Myc with a deletion mis. The phenotype we observe is consistent with a role for Myc in promoting exit from the stem cell comin the transactivation domain (⌬106-143MycER) [6] were generated and found to exhibit no phenotypic response partment.
to OHT (data not shown).
Results

Generation of transgenic mice c-Myc stimulates epidermal proliferation
The dorsal skin of K14MycER and wild-type animals was Four founder lines of transgenic mice were generated that expressed the human c-Myc-2 cDNA fused to the treated daily with OHT for 4 weeks. The treated skin of transgenic animals became greasy and stiff with some hair hormone binding domain (ER TM ) of a mutant murine estrogen receptor (MycER) [12] in a keratin 14 (K14) expresloss, whereas wild-type mouse skin was unaffected by OHT application (data not shown). Wild-type skin was sion cassette [11] (Figure 1a) . Founder line 2184C.1 had 70 copies of the transgene; 2184A had 25 copies; 2184C. 2 histologically normal (Figure 2a -c), but transgenic skin had thickened, hyperproliferative epidermis and abnorhad 2 copies; and 2184C.3 had 1 copy. ER TM lacks intrinsic transactivation activity; it responds to the synthetic steroid mal hair follicles; normal follicle architecture was no longer visible, and the hair fibers were often missing (Fig-4 -hydroxy-tamoxifen (OHT), but not to estrogen, and so in the absence of OHT MycER is inactive [6, 9, 12]. The ure 2d-f). Staining with the proliferation marker Ki 67 (which labels cells in late G1, S, G2, and M phases) re-K14 promoter directs transgene expression in all cells of vealed an increase in the number of actively cycling cells by impaired terminal differentiation [17] . To distinguish between these potential effects of c-Myc, we examined in transgenic skin, the proliferative cells in interfollicular epidermis being predominantly in the basal layer (Figure differentiation of three lineages founded by epidermal stem cells: interfollicular epidermis, sebaceous glands, 2b,e). The interfollicular epidermis was also highly positive for keratin 6, a marker for epidermal hyperproliferaand hair follicles [1, 3, 4] . tion, which in wild-type animals is expressed exclusively
In normal interfollicular epidermis, keratin 1 is expressed in the hair follicles [14] (Figure 2c,f) . Staining for markers in all of the suprabasal layers (Figure 3c ), whereas in of T lymphocytes, neutrophils, and macrophages revealed neoplastic lesions keratin 1 expression is reduced or abonly a small increase in immune infiltrate in OHT-treated sent [9, 10, 17, 18]. Even though OHT-treated transgenic transgenic skin (data not shown). These results make it epidermis was much thicker than control epidermis (Figunlikely that inflammation was responsible for the epiderure 3a,e), keratin 1 was expressed in all the suprabasal mal hyperproliferation. The phenotype was observed in layers ( Figure 3g ). In addition, we noted an increased all founder lines, although it was milder in the low than number of keratin 1-positive cells in the basal layer of the high copy number lines (data not shown). Transgenic transgenic epidermis (Figure 3c,g ), which might be indicamice aged between 7 weeks and 4 months were treated tive of the premature initiation of terminal differentiation. with OHT; they developed the same phenotype regardThe expression of involucrin, filaggrin, and loricrin, markless of age or stage of the hair growth cycle. OHT-treated transgenic epidermis, as in normal epiderdoes not increase the number of rounds of cell division mis (Figure 3d ,h). Thus, although OHT-treated transthat transit-amplifying cells undergo prior to terminal difgenic interfollicular epidermis was hyperproliferative, the ferentiation, nor does it affect the length of the cell cycle keratinocyte terminal differentiation program was essen- [6] . In contrast to the situation in culture, in normal epidertially normal, and the thickened epidermis comprised inmis stem cells are rarely in cycle, whereas transit-amplicreased layers of differentiating cells rather than an infying cells are actively cycling [16] . If the increase in creased number of basal layers. Ki 67-positive cells in OHT-treated transgenic mouse epidermis reflected the recruitment of quiescent stem
Activation of c-Myc stimulates sebocyte differentiation
To examine differentiation of sebaceous gland cells (sebocells into the cycle and entry into the transit-amplifying compartment, the consequence would be excessive procytes), we stained heavily affected transgenic and wildtype skin with Oil Red O, a histochemical dye specific duction of terminally differentiated cells. Alternatively, if it reflected the neoplastic conversion of basal cells, the for lipid-containing cells, including sebocytes ( Figure  4a ,b). In wild-type skin, sebaceous glands were associated increase in Ki 67-positive cells might be accompanied In transgenic mice, the number of sebocytes was greatly increased and filled the center of the abnormal hair follicle-derived structures (Figure 4b , arrows). There was no increase in apoptotic cells in interfollicular epidermis (Figure 4c,d ), and this result is consistent with other studies showing that keratinocytes are resistant to c-Myc-induced apoptosis [6, 9, 10]; although the lesions showing sebocyte differentiation were strongly labeled with TUNEL, the staining was diffuse throughout the cells rather than concentrated in the nucleus and may therefore be nonspecific (Figure 4c,d ). Further evidence that c-Myc promoted sebocyte differentiation came from examining the specialized sebaceous glands of the eyelid (exposed to OHT during grooming), the meibomian glands. Similar to the sebaceous lesions of dorsal skin, the meibomian glands of affected mice were enlarged (arrows in Figure 4e ,f). Some differentiated sebocytes continued to proliferate, and in OHT-treated skin some sebocytes migrated from the hair follicles into the overlying epidermis (data not shown); this premalignant change is a feature of human sebaceous carcinomas [20] .
c-Myc stimulates sebocyte differentiation at the expense of hair differentiation
The third type of differentiation we examined was the formation of hair follicles. Hair follicles continually undergo a defined cycle of growth (anagen), followed by involution (catagen) and a resting phase (telogen) [21] . Although there was hair loss in some OHT-treated transgenic mice, telogen follicles were capable of initiating anagen and the number of hair follicles in the skin was unaltered (unpublished data). However, treated anagen follicles had abnormal morphology, and increased numbers of sebocytes were observed (Figure 4h,j) . Sebaceous differentiation was also stimulated by OHT in telogen follicles (Figure 4g failed to develop a skin phenotype (data not shown). Thus, within 3 days after the last dose of OHT, the transgene should no longer be activated. Transgenic and wild-type animals were treated with OHT for up to one week and then monitored for another 6 days without further application of OHT (Figure 5a ). The transgenic during grooming. This transfer affected the oral epithelium. phenotype was not reversed but became much more severe after termination of the OHT treatment (Figure 5a ).
Even a single treatment with OHT caused progressive
To analyze later time points and to more stringently test whether the epidermal phenotype progressed in the abchanges in the epidermis (Figure 5b) , and in some animals (whether receiving one or multiple doses of OHT) spontasence of OHT treatment, we gave wild-type and transgenic mice a single dose of OHT, and at intervals thereafneous wounds developed (see, for example, Figure 5b , day 15). The mice could not be monitored at later time ter we removed the treated areas and grafted them onto immunocompromised recipient mice. The grafts were repoints; they were sacrificed because they exhibited excessive weight loss as a result of OHT transfer to the mouth covered 4 weeks from the date of OHT treatment. As illustrated in Figure 5c , the phenotype of the transgenic one dose of OHT and sacrificed 2 weeks later, ODC mRNA was absent, except in clusters of cells at the juncskin was more severe than at the time of grafting and had thickened, hyperproliferative epidermis and increased setion between the hair follicles and the epidermis ( Figure  6e ,f). These cells have previously been shown to selecbaceous differentiation, whereas grafts of OHT-treated wild-type skin had normal histology.
tively express ODC in response to phorbol ester treatment [26] . Given that the abnormal follicle phenotype was more highly developed in the one-dose animals examined 2 Ornithine decarboxylase (ODC) is a well-documented weeks later (Figure 6e ) than in the animals treated continc-Myc target gene [25] . We therefore examined ODC uously with OHT for 7 days (Figure 6c ) yet that ODC expression in transgenics treated with a single dose of mRNA was no longer detected in those follicles, we con-OHT as a marker of whether Myc activity could persist clude that continuous c-Myc activity was not required for in the absence of OHT (Figure 6 ). In wild-type epidermis the progression of the phenotype. treated with OHT for 4 weeks, ODC mRNA was undetectable in the interfollicular epidermis and upper portion of the hair follicles, as reported previously [9], although As the histological appearance of transgenic skin treated continuously with OHT or with a single dose was similar a signal was observed at the base of the follicles (Figure  6a,b) . In transgenic mice treated continuously for 7 days ( Figure 5 ), it seemed likely that one dose of OHT was sufficient to trigger prolonged epidermal hyperprolifera- (Figure 6c 
7). Five days after a single dose of OHT, Ki 67 and BrdU
crease in the number of differentiated cell layers. We propose that transient c-Myc activation recruits quiescent labeling were stimulated; the increase in labeling was still evident 14 days after OHT treatment (Figure 7a-i and stem cells into cycle and thereby promotes entry into the transit-amplifying compartment, which in turn leads to unpublished data). When epidermis that had a single OHT dose was compared with epidermis treated continuterminal differentiation along the sebaceous and interfollicular epidermal lineages (Figure 8 ). Why sebocyte differously for an equivalent period of time, the degree of labeling was similar (see, for example, Figure 7b ,g,e,j).
entiation is stimulated at the expense of hair type differentiation is unclear at present, but it may reflect the need Thus, a single dose of OHT resulted in sustained proliferation, accounting for the progressive thickening of the for additional inducing factors, in particular Wnts, for hairtype differentiation [27] . interfollicular epidermis with time after treatment.
Discussion
One characteristic of transit-amplifying cells is that they undergo only a small number of rounds of division (variThe aim of our experiments was to test whether activation of c-Myc in basal keratinocytes in vivo stimulated exit ously estimated as 3-5 [1] ) prior to terminal differentiation. If exit from the stem cell compartment is stimulated from the stem cell compartment, as observed in vitro [6], or whether it suppressed terminal differentiation, as at the expense of self-renewal, divisions in the transitamplifying compartment should eventually be exhausted observed when Myc is selectively activated in the differentiating epidermal layers [9] . A single application of and the epidermis should become thinner, with loss of proliferation in the basal layer. However, even 30 days OHT was as effective as repeated treatments in stimulating proliferation. However, the terminal differentiation after a single dose of OHT, the epidermis of K14MycER mice was hyperproliferative (Figures 5 and 7) . There are pathway in interfollicular epidermis was executed normally, the thickening of the epidermis reflecting an intwo possible explanations for this. One is that, as the keratin 14 promoter is expressed in both stem and transitand transit-amplifying cells that are equivalent to those currently available for human epidermis [1, 5, 6] , it should amplifying cells [11] , Myc activation increases the number of rounds of division that transit cells undergo prior be possible to use the K14MycER mice to obtain an estimate of the size of the transit-amplifying compartment to terminal differentiation. In culture, the activation of MycER with OHT does not increase the number of transit and to determine whether the number of rounds of division that transit-amplifying cells undergo prior to terminal amplifying-cell divisions, nor does it affect the length of the cell cycle [6]; however, in culture the stem cells are differentiation is fixed or responsive to environmental modulation. A further issue is whether Myc is acting solely actively cycling, whereas in vivo they cycle infrequently. The second possibility is that although the production of on the keratinocyte proliferation machinery or has additional indirect effects, such as altered production of transit-amplifying cells is stimulated, the stem compartment continues to be replenished. growth factors [9] , that could affect the interaction between the epidermis and the underlying mesenchymal cells [28] . By the discovery of markers of mouse epidermal stem be a consequence of c-Myc misexpression. The activation of Myc in basal keratinocytes could also contribute to neoplasia because any basal keratinocyte that has accumulated genetic lesions resulting in resistance to cell loss through Myc-induced terminal differentiation or apoptosis would clearly have a selective growth advantage and the potential to form a tumor.
Conclusions
The phenotype of the K14MycER mice is consistent with a role for c-Myc in stimulating exit from the epidermal stem cell compartment. The mice allow us to manipulate the adult stem cell compartment in vivo and are a valuable tool for exploring the factors that regulate lineage decisions by epidermal stem cells, as well as the relationship between stem cells and cancer. be Myc-induced histone acetylation and chromatin remodeling [31] , but this remains to be investigated.
Experimental treatments of mice
The c-MycER transgene was activated in transgenic mice by topical The neoplastic phenotype induced by the expression of the back skin of Balb/c nude mice, essentially as described previously for grafts of reconstituted human skin [36] . sections were prepared and stained with hematoxylin and eosin. frozen sections, essentially as described by Catalano and Lillie [38] . 
